CRMK yields 16666.67% · PFE yields 6.13%● Live data
📍 CRMK pulled ahead of the other in Year 1
Combined, CRMK + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRMK + PFE for your $10,000?
Cermetek Microelectronics, Inc. designs, manufactures, and markets Internet appliance modems, modem components, and telephone line interfaces for the data communications industry. The company offers Internet connectivity devices, embedded device servers, high-speed modems, low-speed modems, modem modules, wireless data modules, embedded wireless devices, modules for wireless sensor networks, Internet protocol equipped modems, data access arrangements, and embedded Ethernet modules; and communications components for embedded communications. Its products are used in Internet appliance, embedded industrial, telecom, security/alarm, remote diagnostic and energy monitor, remote sensor, and conservation applications. The company sells its products to industrial OEMs through sales representatives and distributors in Australia/New Zealand, Mexico, France, Germany, Israel, Korea, Southeast Asia, Spain, Switzerland, Israel, North America, and Italy; and enables users to order online. Cermetek Microelectronics, Inc. was formerly known as Cermetek, Inc. The company was founded in 1968 and is based in Milpitas, California.
Full CRMK Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.